| Literature DB >> 31330935 |
Rodrigo Poderoso1, Maria Cirilo-Sousa2,3, Adenilson Júnior4, Jefferson Novaes5,6, Jeferson Vianna6, Marcelo Dias7, Luis Leitão8,9, Victor Reis10, Nacipe Neto11,12, José Vilaça-Alves13.
Abstract
This study was designed to analyze the chronical responses of the hormonal and immune systems after a CrossFit® training period of six months as well as to compare these results between genders. Twenty-nine CrossFit® practitioners (35.3 ± 10.4 years, 175.0 ± 9.2 cm, 79.5 ± 16.4 kg) with a minimum CrossFit® experience of six months were recruited, and hormonal and immune responses were verified every two months during training. The training was conducted in five consecutive days during the week, followed by two resting days. Testosterone (T) values were significantly higher at the last measurement time (T6 = 346.0 ± 299.7 pg·mL-1) than at all the other times (p < 0.002) and were higher in men than in women (p < 0.001). Cortisol (C) levels were lower at all times compared to the initial level before training, and differences were observed between men and women, with men having a lower value (T0: p = 0.028; T2: p = 0.013; T4: p = 0.002; and T6: p = 0.002). The TC ratio in women was lower at all times (p < 0.0001) than in men. Significant effects on CD8 levels at different times (F(3.81) = 7.287; p = 0.002; ηp2 = 0.213) and between genders (F(1.27) = 4.282; p = 0.048; ηp2 = 0.137), and no differences in CD4 levels were observed. CrossFit® training changed the serum and basal levels of testosterone and cortisol in men (with an increase in testosterone and a decrease in cortisol).Entities:
Keywords: CrossFit; RPE; hormonal responses; immunological responses
Mesh:
Substances:
Year: 2019 PMID: 31330935 PMCID: PMC6678899 DOI: 10.3390/ijerph16142577
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Training sessions distribution per exercise modality.
| Week | Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday |
|---|---|---|---|---|---|---|---|
| Week 1 | M | G + W | M + G + W | M + G | W | Rest | Rest |
| Week 2 | G | M + W | M + G + W | G + W | M | Rest | Rest |
| Week 3 | W | M + G | M + G + W | M + W | G | Rest | Rest |
M: Metabolic conditioning exercises; G: Gymnastics exercises; W: Weightlifting exercises.
Participants’ anthropometric measurements and practice time.
| Variables | Men | Women | |
|---|---|---|---|
| Age (years) | 34.7 ± 7.5 | 36.1 ± 13.6 | 0.7417 |
| Height (cm) | 180.7 ± 4.8 | 166.8 ± 7.5 | 0.0000 † |
| Total Body Mass (kg) | 89.2 ± 7.1 | 65.5 ± 15.7 | 0.0000 † |
| Estimated Body Fat (%) | 17.6 ± 2.1 | 23.5 ± 4.8 | 0.0013 † |
| Practice Time (months) | 9.4 ± 2.7 | 8.8 ± 1.9 | 0.5076 |
† Difference between men and women.
Mean ± standard deviation of testosterone (T) and cortisol (C) levels and the ratio of testosterone to cortisol (T/C) at different measurement times in men and women.
| Variable | T0 | T2 | T4 | T6 |
|---|---|---|---|---|
|
| ||||
| Testosterone (pg·mL−1) | 261.7 ± 249.3 | 289.5 ± 232.6 | 298.7 ± 258.5 | 346.0 ± 299.7 * 0,2,4, a |
| Cortisol (pg·mL−1) | 18.0 ± 8.2 | 18.1 ± 9.7 | 15.6 ± 6.3 * 0, c | 14.6 ± 5.6 * 0,2, d |
| T/C | 18.1 ± 19.7 | 21 ± 20.3 | 23 ± 22.8 | 28.1 ± 27.2 |
|
| ||||
| Testosterone (pg·mL−1) | 421.2 ± 207.6 †† | 451.4 ± 143.9 †† | 473.7 ± 189.4 | 564.7 ± 185.3 * 0,2,4, ††, b |
| Cortisol (pg·mL-1) | 15.6 ± 5.2 † | 15 ± 5.4 † | 13.3 ± 4.3 * 0, †, e | 12.6 ± 3.4 * 0,2,4, †, e, f †, g |
| T/C | 30.4 ± 18 | 34.6 ± 16.2 | 37.8 ± 19.2 | 47.6 ± 19.6 |
|
| ||||
| Testosterone (pg·mL−1) | 35.7 ± 21.9 | 60.2 ± 99 | 50.8 ± 60 | 36.3 ± 14.1 |
| Cortisol (pg·mL−1) | 22.6 ± 9.1 | 23.8 ± 11.3 | 19.6 ± 6.5 | 18.3 ± 60 |
| T/C | 1.7 ± 0.9 | 2.7 ± 3.6 | 3.2 ± 4.8 | 2.1 ± 0.9 |
* 0,2,4 Difference compared to T0, T2, and T4, respectively (p < 0.05); † Difference compared to women (p < 0.05); †† Difference compared to women (p < 0.0001); a T0 (p = 0.001), T2 (p = 0.002), and T4 (p = 0.001); b T0 (p = 0.001), T2 (p = 0.003), and T4 (p = 0.001); c T0 (p = 0.022); d T0 (p < 0.0001) and T2 (p = 0.00); e T0 (p = 0.049); f † T0 (p = 0,028), T2 (p = 0.013), T4 (p = 0.002), and T6 (p = 0.002); g T0 (p = 0.003) and T2 (p = 0.023).
Mean ± standard deviations of lymphocytes CD4 and CD8 values at different measurement times.
| Variable | T0 | T2 | T4 | T6 |
|---|---|---|---|---|
|
| ||||
| CD4 (cells/mm3) | 1100.5 ± 307.0 | 1026.9 ± 305.6 | 1045.7 ± 275.5 | 1118.8 ± 242.2 |
| CD8 (cells/mm3) | 664.9 ± 220.9 | 582.3 ± 226.4 | 623.4 ± 195.4 | 672.4 ± 196.9 * 2,4 |
| CD4/CD8 | 1.66 ± 1.39 | 1.76 ± 1.35 | 1.68 ± 1.41 | 1.66 ± 1.23 |
|
| ||||
| CD4 (cells/mm3) | 1108.1 ± 270.5 | 1065.8 ± 328.0 | 1053.7 ± 284.8 | 1126.2 ± 249.2 |
| CD8 (cells/mm3) | 723.0 ± 231.9 | 659.4 ± 243.8 † | 673.2 ± 208.2 | 728.3 ± 208.5 * 2,4 |
| CD4/CD8 | 1.53 ± 1.17 | 1.62 ± 1.35 | 1.57 ± 1.37 | 1.55 ± 1.19 |
|
| ||||
| CD4 (cells/mm3) | 1089.6 ± 365.0 | 971.7 ± 275.0 | 1034.4 ± 274.0 | 1108.3 ± 242.6 |
| CD8 (cells/mm3) | 582.5 ± 182.9 | 473.1 ± 147.5 | 553.0 ± 157.8 | 593.1 ± 154.0 * 2 |
| CD4/CD8 | 1.87 ± 2.0 | 2.05 ± 1.86 | 1.87 ± 1.74 | 1.87 ± 1.58 |
* 2,4 Difference compared to T2 and T4, respectively (p < 0.05); † Difference compared to women (p < 0.05).